STIM Earnings — Neuronetics, Inc. Common Stock Post-ER Performance | BigEarnings
STIM — Neuronetics, Inc. Common Stock
XNAS · Healthcare · Medical Devices
Price$1.54
Market Cap$107.2M
P/E—
52W Range$0.80 – $4.85
Next Earnings2026-08-04
About Neuronetics, Inc. Common Stock
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
